http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e22e6e79075e3b3e379b62d06e9da97
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Kannagi |
| name | Reiji. Kannagi Reiji Kannagi |
| given-name | Reiji. Reiji |
| organization-name | 1Department of Molecular Pathology, Aichi Cancer Center;; 3CREST, Japan Science and Technology Agency, Kawaguchi; Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan Institute of Biomedical Sciences Academia Sinica Taipei Taiwan Institute of Biomedical Sciences, Academia Sinica, Nankang, Taipei 115, Taiwan Research Complex for Medical Frontiers, Aichi Medical University, Yazako, Nagakute 480-1195, Japan; Department of Clinical Science, Faculty of Medicine Kyoto University Sakyo‐ku, Kyoto Kyoto 606 rkannagi@aichi-cc.jp 1Department of Molecular Pathology, Aichi Cancer Center Research Institute, Nagoya;; 2Science and Technology Agency, Kawaguchi; The Institute of Biomedical Sciences (IBMS), Academia Sinica, Taipei, Taiwan. rkannagi@ibms.sinica.edu.tw. Division of Molecular Pathology, Aichi Cancer Center Research Institute, Nagoya, Japan. rkannagi@ibms.sinica.edu.tw. The Institute of Biomedical Sciences (IBMS), Academia Sinica, Taipei, Taiwan. Department of Molecular Pathology, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya 464-8681, Japan. rkannagi@aichi-cc.jp From the Division of Molecular Pathology, Aichi Cancer Center, Chikusa-ku, Nagoya; Department of Infectious Disease and Immunology, Faculty of Medicine, Okinawa-Asia Research Center of Medical Science, University of the Ryukyus, Nishihara; and Department of Cellular and Molecular Biology, The Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Japan. Graduate Institute of Life Sciences National Defense Medical Center Taipei Taiwan; Institute of Biomedical Sciences Academia Sinica Taipei Taiwan Department of Molecular Pathology, Aichi Cancer Center, Research Institute. Research Complex for Medical Frontiers, Aichi Medical University, Yazako, Nagakute, Japan 5The Department of Molecular Pathology, Aichi Cancer Center, Chikusa-ku, Nagoya, Japan; and Department of Molecular Pathology, Aichi Cancer Center Research Institute. From the Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan (Y.-C.L., R.K., R.-B.Y.) Program of Experimental Pathology, Aichi Cancer Center, Nagoya 464-8681; Department of Biochemistry, Nagoya University School of Medicine, Nagoya 466-8550; Pharmaceutical Frontier Research Laboratories, JT, Inc., Yokohama 236-0004, Japan; and Department of Microbiology-Immunology, Northwestern University, Medical School, Chicago, IL 60611-3008 Department of Molecular Pathology, Aichi Cancer Center, Nagoya, Japan; Authors' Affiliations: 1Department of Molecular Pathology, Aichi Cancer Center, Nagoya, Japan and 2Research Complex for the Medicine Frontiers, Aichi Medical University, Aichi, Japan; Authors' Affiliations: 1Department of Molecular Pathology, Aichi Cancer Center, Nagoya, Japan and 2Research Complex for the Medicine Frontiers, Aichi Medical University, Aichi, Japan Department of Molecular Pathology, Aichi Cancer Center, Chikusaku, Nagoya, Japan. Research Complex for the Medical Frontiers, Aichi Medical University, Aichi 480-1195, Japan. kannagi-gi@umin.ac.jp Program of Experimental Pathology, Aichi Cancer Center, Nagoya 464-8681, Japan; Central Clinical Laboratory, Kyoto University School of Medicine, Kyoto 606-8501, Japan; and Department of Applied Bioorganic Chemistry, Gifu University, 501-1193 Gifu, Japan Fred Hutchinson Cancer Research Center Department of Molecular Pathology, Aichi Cancer Center, Chikusaku From the Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan (Y.-C.L., S.R.R., R.K., R.-B.Y.); Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taiwan (T.-Y.C., C.-T.Y.); Division of Hematology/Oncology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan (T.-Y.C.); Department of Medical Research and Education, Shuang Ho Hospital, Taipei Medical University, Taiwan (C.-T.Y.); and Institute of... *Department of Molecular Pathology, Aichi Cancer Center, Research Institute, Nagoya 464-8681, Japan;; ‡Department of Gastroenterology, Research Institute, International Medical Center of Japan, Tokyo 162-8655, Japan;; #Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan Laboratory of Experimental Pathology, Aichi Cancer Center Research Institute , Nagoya, Japan Departments of *Molecular Pathology and; Core Research for Evolutionary Science and Technology, Japan Science and Technology Agency, Kawaguchi 332-0012, Japan; and *Department of Anatomy and Program in Immunology, and ‡Cardiovascular Research Institute, University of California, San Francisco, California 94143; §Program in Experimental Pathology, Aichi Cancer Center, Nagoya, Japan; ‖Clontech Laboratories, Inc., Palo Alto, California 94303; and ¶Department of Respiratory Diseases, Roche Bioscience, Palo Alto, California 94304-1397 Department of Molecular Pathology, Aichi Cancer Center. Division of Molecular Pathology, Aichi Cancer Center, Chikusa-ku, Nagoya, Aichi 464-8681, Japan;; Research Complex for Medical Frontiers, Aichi Medical University, Yazako, Nagakute, Aichi 480-1195, Japan; and; Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan |
Incoming Links
Total number of triples: 230.